Insurance Coverage and Access Requirements for Lower-Emission Inhalers in US Commercial Health Plans
This cross-sectional study assesses formulary coverage, patient cost-sharing, and prior authorization requirements for lower-emission inhalers among patients with asthma or chronic obstructive pulmonary disease across US commercial insurance plans.
Authors
- Soko Setoguchi (ORCID: https://orcid.org/0000-0002-1583-752X)
- Ashwaghosha Parthasarathi (ORCID: https://orcid.org/0000-0002-7270-0247)
- Reynold A. Panettieri (ORCID: https://orcid.org/0000-0003-0834-4636)
- Adithi Chellappan
- Paras Modha
- Chloe Kline
Institutions
- Rutgers, The State University of New Jersey (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-09-28
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.34318
- Citations
- 1
- Primary Topic
- Inhalation and Respiratory Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 4.76